Medtech experts share advanced praise for the second edition of the Biodesign textbook

“Biodesign is on the forward edge of one of the most exciting new frontiers of health care. This impressive and engaging work provides a thorough look at the innovation process.  But this is certainly not just for the scientific innovators: it is a must-read for anyone in any aspect of health care today.”

Alex Gorsky, Chairman and CEO, Johnson & Johnson

“I can’t think of a more important place to turn creativity loose than in designing the future of healthcare. But it’s a complicated scene – and it’s easy to get lost in the maze of stakeholders, regulation, and financing. Biodesign lays out a clear and logical map to find and pursue opportunities for real innovation. One of the core messages in this new edition is that by placing the need for affordability up front in design process, innovators can more explicitly create technologies that bring value to the healthcare system. This is design thinking at its best!”

David Kelley, Founder, Hasso Plattner Institute of Design at Stanford University and Founder, IDEO

“A must-to-read textbook for anyone in academia or industry, in any country, who wants to innovate and deliver value to patients and health systems around world.”

Koji Nakao, Chairman of Terumo and the Japanese Federation of Medical Device Associations

“If you want to know how to come up with a both innovative and transformative technology in medicine, there isn’t a better resource than this book by Paul Yock and his colleagues at Biodesign. Over 13 years ago, the program at Stanford brought together trans-disciplinary innovators—engineers, physicians and business experts– to not only design their formidable program, but to teach all the rest of us how to do it.”

Eric J. Topol, Director, Scripps Translational Science Institute

 “This book on biodesign will be invaluable for any inventor or entrepreneur. It contains very useful information on such critical areas as design principles, regulatory issues, clinical trial strategies, intellectual property, reimbursement strategies, and funding- and it backs them up with interesting real life experiences and case studies”.

Robert Langer, David H. Koch Institute Professor, MIT

“This practical but comprehensive resource is keeping up with the rapid developments affecting medical device innovation. The authors draw on their own extensive experiences and insights, as well as diverse case studies, to present the full range of strategic and operational considerations to bring valuable new therapies to patients in the US and around the world.”

Mark McClellan, Director, Health Care Innovation and Value Initiative, Brookings Institution

This entry was posted in Updates. Bookmark the permalink.